Compile Data Set for Download or QSAR
Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 12479
TargetProtein arginine N-methyltransferase 5(Human)
Cytosinlab Therapeutics

US Patent
LigandPNGBDBM705313(US20240376126, Example 4)
Affinity DataIC50: 1.70nMAssay Description:1. Enzyme Reaction Process(1) 1× Assay buffer (modified Tris buffer) was configured.(2) Dilute compound: the compound was dissolved in 100% DMSO and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/20/2025
Entry Details
Go to US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Cytosinlab Therapeutics

US Patent
LigandPNGBDBM705316(US20240376126, Example 146)
Affinity DataIC50: 2.5nMAssay Description:1. Enzyme Reaction Process(1) 1× Assay buffer (modified Tris buffer) was configured.(2) Dilute compound: the compound was dissolved in 100% DMSO and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/20/2025
Entry Details
Go to US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Cytosinlab Therapeutics

US Patent
LigandPNGBDBM705318(US20240376126, Example 148)
Affinity DataIC50: 2.60nMAssay Description:1. Enzyme Reaction Process(1) 1× Assay buffer (modified Tris buffer) was configured.(2) Dilute compound: the compound was dissolved in 100% DMSO and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/20/2025
Entry Details
Go to US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Cytosinlab Therapeutics

US Patent
LigandPNGBDBM705317(US20240376126, Example 147)
Affinity DataIC50: 2.90nMAssay Description:1. Enzyme Reaction Process(1) 1× Assay buffer (modified Tris buffer) was configured.(2) Dilute compound: the compound was dissolved in 100% DMSO and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/20/2025
Entry Details
Go to US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Cytosinlab Therapeutics

US Patent
LigandPNGBDBM705312(US20240376126, Example 2)
Affinity DataIC50: 3nMAssay Description:1. Enzyme Reaction Process(1) 1× Assay buffer (modified Tris buffer) was configured.(2) Dilute compound: the compound was dissolved in 100% DMSO and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/20/2025
Entry Details
Go to US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Cytosinlab Therapeutics

US Patent
LigandPNGBDBM705314(US20240376126, Example 127)
Affinity DataIC50: 3.70nMAssay Description:1. Enzyme Reaction Process(1) 1× Assay buffer (modified Tris buffer) was configured.(2) Dilute compound: the compound was dissolved in 100% DMSO and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/20/2025
Entry Details
Go to US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Cytosinlab Therapeutics

US Patent
LigandPNGBDBM705315(US20240376126, Example 132)
Affinity DataIC50: 4.40nMAssay Description:1. Enzyme Reaction Process(1) 1× Assay buffer (modified Tris buffer) was configured.(2) Dilute compound: the compound was dissolved in 100% DMSO and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/20/2025
Entry Details
Go to US Patent

TargetProtein arginine N-methyltransferase 5(Human)
Cytosinlab Therapeutics

US Patent
LigandPNGBDBM705311(US20240376126, Example 1)
Affinity DataIC50: 5.10nMAssay Description:1. Enzyme Reaction Process(1) 1× Assay buffer (modified Tris buffer) was configured.(2) Dilute compound: the compound was dissolved in 100% DMSO and ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/20/2025
Entry Details
Go to US Patent